All News

In the wake of last year's fungal meningitis tragedy, the Specialty Sterile Pharmaceutical Society brings a new voice to an industry under fire.

Grass-roots successes achieved at the state and local levels support federal initiatives pursued by the national pharmacy organization.

Patients in rural settings can still receive personalized care from pharmacists. With tele consults, all they need is an internet connection and a laptop.

After manufacturers began printing new warnings on medicine bottles, a smaller percentage of emergency room visits resulted from children taking cold and cough products, according to a study in Pediatrics.

Vertex Pharmaceuticals is shifting its investment strategy to focus on opportunities in cystic fibrosis, according to CFO Ian Smith, who spoke at the Credit Suisse 2013 Healthcare Conference in mid November.

Popular contributor "Goose" Rawlings offers a simple solution to a universal problem.

With obesity rates growing and diabetes diagnoses going up, healthcare providers are focusing on the need to treat GDM in both mother and unborn child.

How can an independent pharmacy survive in the face of competition from the mega-chains? Here's a clue.

When it comes to knowledge of medications and their actions, pharmacists have it way over most physicians. For the sake of the patient, you have to speak up, whether the doc likes it or not.

In disaster relief, inappropriate pharmaceutical donations and/or a disorganized receiving operation can mean that tons of medications go straight into the rubbish.

A small study of patients undergoing bariatric surgery suggests that weekly warfarin doses can change by as much as 20% postoperatively.

The bicameral legislation provides specific requirements for all stakeholders in the drug-distribution supply chain, including manufacturers, wholesalers, repackagers, and pharmacies.

CSL Behring's Kcentra is is currently the only 4-factor PCC available in the United States.

Use of both AACE and ADA/EASD guidelines can benefit physicians, pharmacists, and other healthcare practitioners.

Drug Topics’ legal compliance columnist named partner in Roetzel's Chicago office and head of the firm’s Drug and Pharmacy practice.

Product updates for pharmacists: New Rx, generic, and OTC

Technology-based messaging support for at-risk and diabetic patients is being tested in 17 communities across the country. Three of the participating programs have released their evaluations and conclusions.

Drug Topics readers have their say.

A peek into a very special world.

The American Society of Health-System Pharmacists is backing FDA’s recommendation that hydrocodone combination products be reclassified as Schedule II drugs under the Controlled Substances Act.

A former Ranbaxy executive told CBS News that the company often skipped the required steps for approval of its generic drugs, and in some cases presented fake data to get its products in U.S. pharmacies.

Representatives of Boehringer Ingelheim reported the data at the 64th Annual Meeting of the American Association for the Study of Liver Diseases.

For years, Bernie Lisitza owned small pharmacies in the Chicago area. He eventually traded his dual role as owner and pharmacist and went to work for Omnicare, which dispenses prescriptions for nursing homes throughout the country.

The National Association of Chain Drug Stores and the National Community Pharmacists Association have endorsed legislation that would restore the ability of consumers to purchase OTC medications using pre-tax dollars from flexible spending accounts and health savings accounts without obtaining a doctor’s endorsement.

Aaron Jennissen, VP, Pharmacy Operations, Thrifty White Pharmacy, discusses how that chain is using telepharmacy to improve both customer loyalty and reach.

FDA has approved a new boxed warning for the anti-seizure drug ezogabine (Potiga) because of the potential risk of vision loss, retinal abnormalities, as well as skin, nail, mucous membrane, and sclera discoloration.

Short-term dual antiplatelet therapy was as effective as long-term therapy for patients who underwent percutaneous coronary intervention (PCI) with a second-generation drug-eluting stent, according to an online study published in JAMA.

Citing the risk of life-threatening blood clots and severe narrowing of blood vessels, FDA has asked Ariad Pharmaceuticals to suspend marketing and sales of ponatinib (Iclusig).

Once-daily dosing of the investigational drug tiotropium helped to improve lung function over 24 hours in individuals with severe asthma, according to data presented at the 2013 American College of Chest Physicians annual meeting (CHEST 2013) in Chicago.